doi: 10.2903/j.efsa.2021.6555
Were seeing GLP-1 drugs show tremendous promise across a wide range of conditions, including improving markers of body-wide and brain inflammation, which is common in long COVID, says Eric Topol, executive vice president of Scripps Research and co-principal investigator of LoCITT
Watch for these warning signs: No pharmacy name on the bottle label Research peptide sites that ship in unmarked vials Pricing far below the market floor (under $150/month for semaglutide is suspicious) Vendors who ship from outside the US, especially China, India, or Russia No prescription required No clinical intake or licensed prescriber Legitimate compounded semaglutide always requires a US-licensed prescriber, a real prescription, and a US-based 503A pharmacy
Keep your vial in its original box inside the fridge
Medications like Semaglutide, Tirzepatide, and the emerging Retatrutide represent significant advancements in this field